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Abstract.  We have isolated a  mutant line of mouse L 
cells, termed gro29,  in which the growth of herpes 
simplex virus (HSV) and vesicular stomatitis virus 
(VSV)  is defective. The block occurs late in the infec- 
tious cycle of both viruses. We demonstrate that HSV 
and VSV enter gro29 cells normally, negotiate the 
early stages of infection, yet are impaired at a late 
stage of virus maturation. During VSV  infection of the 
mutant cell line, intracellular transport of its glycopro- 
tein (G protein) is slowed. Pulse-chase experiments 
showed that oligosaccharide processing is impeded, 
and immunofluorescence localization revealed an ac- 
cumulation of G  protein in a juxtanuclear region that 
contains the Golgi complex. We conclude that export 
of newly made glycoproteins is defective in gro29 
cells, and speculate that this defect may reflect a  lesion 
in the glycoprotein transport apparatus. 
UKARYOTIC cells utilize an elaborate transport system 
to move newly synthesized membrane and secretory 
proteins from their site of synthesis to their sites of 
action.  Proteins synthesized in the endoplasmic reticulum 
(ER) I move to the Golgi complex before being sorted for 
transport to cellular organelles or the cell surface. Transport 
and sorting require an apparatus that ensures the delivery of 
individual proteins to correct locations. Although substantial 
progress  is  being  made  in  identifying the  protein  deter- 
minants that influence transport and processing (reviewed by 
Garoff, 1985), less is known about how these determinants 
are  recognized  and  acted  upon  by  the  cellular transport 
machinery. 
One means of dissecting the transport apparatus of eukary- 
otic cells is to isolate cellular mutants defective in this pro- 
cess. This approach has begun to define the secretory path- 
way in yeast. Shekman and colleagues have isolated a large 
collection of mutants that are conditionally defective in par- 
ticular steps in intracellular protein transport (Novick and 
Shekman, 1979; Novick et al., 1980; Esmon et al., 1981; No- 
vick et al.,  1981; Stevens et al.,  1982). Genetic analyses of 
these secretion (sec) mutants indicate that the function of at 
least 20 different gene products is required between the time 
secretory proteins enter the ER and the time they are released 
at the plasma membrane. 
Significant progress has also been made in the reconstitu- 
tion of systems that carry out intracellular transport in vitro; 
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particularly from the study of cultured mammalian cells. 
Rothman and co-workers have documented the transfer of 
glycoproteins between isolated Golgi vesicles (reviewed by 
Dunphy and Rothman,  1985),  and have used this recon- 
stituted system to study vesicular transport in vitro. More re- 
cently, in vitro systems that carry out intravesicular transfer 
via the endocytic pathway have been described (Davey et al., 
1985).  Somatic cell mutants defective in glycoprotein pro- 
cessing (Gottlieb et al., 1975) have facilitated these in vitro 
studies.  Unfortunately, attempts to isolate mammalian cell 
mutants defective in the transport process  itself have met 
with little success. Selections for cells that are resistant to 
lectins, or cells that fail to express specific glycoproteins, 
have tended to yield mutants that are directly impaired in 
oligosaccharide synthesis or processing (reviewed by Stan- 
ley, 1984). To date, there are no reliable methods that facili- 
tate the selection of animal cell mutants affected in protein 
transport. 
During the course of a broader study to identify host cell 
functions required for herpes simplex virus (HSV) infection, 
we isolated a mouse L cell mutant that is defective in glyco- 
protein transport. This mutant, termed gro29, was isolated 
from a collection of mutagenized L cells that were selected 
for their ability to survive infection by HSV (Tufaro, F., and 
S.  McKnight,  manuscript  in  preparation).  Initial  experi- 
ments suggested that the block to HSV infection in this cell 
line occurred at a time when viral glycoprotein synthesis and 
virion assembly take place. The cellular defect also affected 
the production of vesicular stomatitis virus (VSV), which en- 
codes a single envelope glycoprotein (G protein) that is es- 
sential for its infectivity. 
In this paper we show that gro29 cells are defective in the 
transport of VSV G protein through the secretory apparatus 
to the cell surface. We also show by several criteria that en- 
docytosis is unaffected in gro29 cells. It appears, therefore, 
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port pathway. To our knowledge this study represents the first 
characterization of a mammalian  cell  mutant that exhibits 
this phenotype. 
Materials and Methods 
Materials 
The parental cells used for all experiments was the clone 1D line of LMtk- 
mouse fibroblasts. HSV type 1 (KOS strain) was a gift from D. Coen (Har- 
vard Medical School, Boston, MA). VSV (Indiana strain) was a gift from 
H.  Lodish  (Whitehead  Institute  for  Biomedical  Research,  Cambridge, 
MA). Monoclonal antibody to VSV G protein was provided by L. Lefran- 
cois (Upjohn Co., Kalamazoo, MI).  Polyclonal antiserum against HSV-1 
proteins was provided by G. Hayward (The Johns Hopkins University, Balti- 
more,  MD).  Fluorescein- and rhodamine-conjugated second antibodies 
were purchased from Cooper Biomedical, Inc., Malvern, PA. 
Isolation of  Mutant Cell Lines 
Mouse L cells were grown in 150-mm plastic dishes containing Dulbecco's 
modified Eagle's medium and 10% fetal calf serum (DME-FCS). Roughly 
1 x  108 cells growing in three dishes were mutagenized for 18 h with 300 
~tg/ml ethyl methanesulfonate (Sigma Chemical Co., St. Louis, MO). After 
mutagenesis, the cells were grown for 2 d in DME-FCS, split 1:2, and grown 
for an additional 5 d before selection. Cells were infecl~xl with HSV-1 at an 
MOI (multiplicity of infection) of 1 plaque-forming unit (pfu)/cell. This 
resulted in the rapid death (within 72 h) of most mutagenized cells and all 
nonmutagenized (control) L cells. About 1 in l06 of the original population 
of mutagenized cells survived to form colonies. 
Indirect Immunofluorescence 
Cells were grown on glass coverslips in the bottom of 35-mm plastic dishes. 
All further manipulations were performed at 20°C. For fixation, cells were 
rinsed with phosphate-buffered saline (PBS), and incubated in 1% formal- 
dehyde in PBS for 10 min. Fixation was stopped by rinsing ceils in PBS con- 
taining 1% bovine serum albumin (PBS-BSA). Cells were incubated in PBS- 
BSA containing 0.25 % saponin (to permeabilize the cells) and appropriately 
diluted antiserum for 30 rain, rinsed, and incubated in rhodamine-conju- 
gated second antibody (goat anti-rabbit IgG for HSV antigen detection and 
goat anti-mouse IgG for VSV G protein detection). Cells were examined 
and photographed with a  Zeiss IM-35 epifluorescence microscope (Carl 
Zeiss, Inc., Thornwood, NY) using oil-immersion objectives and barrier 
filters. 
For colocalization studies, ceils were fixed for 15 min and washed in 
PBS-BSA for 20 min. To detect intracellular wheat germ agglutinia (WGA)- 
binding sites, cells were incubated for 90 min with 75  I~g/ml unlabeled 
WGA, rinsed with PBS-BSA, and fixed for 15 min. Cells were then permea- 
bilized with acetone, and incubated for 30 min with fluorescein-conjugated 
WGA (25  ~tg/ml in PBS supplemented with 700 ~tM calcium and 300 ~tM 
magnesium) to detect internal WGA-binding sites. VSV G  protein was 
visualized in the same cells using anti-VSV G protein monoclonal antibody 
and rhodarnine-conjugated goat anti-mouse IgG. Fields of ceils were exam- 
ined and photographed using filter combinations that eliminated crossover 
between rhodamine and fluorescein fluorescence channels. 
Analysis of  HSV-l-infected Cell Polypeptides 
Cells were grown in 60-mm culture dishes and infected with HSV-1 at an 
MOI of 5 pfu/cell. At selected intervals (hours postinfection, hpi) cells were 
rinsed in labeling medium (minimal essential medium [MEM] containing 
10% of the normal amount of methionine, normal amounts of nonessential 
amino acids and 2% FCS), and labeled for 3 or 9 h in medium containing 
500  IxCi/ml  [35S]methionine  (Amersham Corp., Arlington Heights, IL). 
At the end of the labeling period, cells were lysed in SDS sample buffer 
(0.0625  M  Tris,  pH 6.8, 2.3%  SDS, 5%  13-mercaptoethanol,  10%  glyc- 
erol)  and  subjected to  SDS-polyacrylamide gel  electrophoresis (PAGE) 
(Laemmli, 1970). Gels were dried and exposed to Kodak XAR-5 film (East- 
man Kodak Co., Rochester, NY). 
Pulse-Chase Labeling of VSV-infected Cells 
Cells were grown in 35-mm culture dishes and infected with VSV at an MOI 
of 10 pfu/cell. Infected cells were labeled with [3~S]methionine in methio- 
nine-free  labeling medium as described by Zilberstein et al. (1980). Medium 
contained 2 I~g/ml actinomycin D throughout infection. At 4 hpi, cultures 
were rinsed three times with labeling medium and then pulse-labeled for 
10 min in 0.2 ml of labeling medium containing 200 lxCi/ml  l~SS]methio  - 
nine. The medium was then removed, and the cultures were rinsed and fed 
with DME-FCS.  At selected intervals after labeling,  the cultures  were 
washed with PBS and lysed in 1% NP-40, 1% sodium deoxycholate, 10 mM 
Tris HCI, pH 7.4,  150 mM NaCI.  Cold acetone (4 vol) was added and 
precipitates were collected by centrifugation (1,000 g, 10 rain). Virions were 
collected from the medium by centrifugation as described previously (Lod- 
ish and Kong, 1983). Pelleted samples were dissolved in 100 Itl of 1% SDS, 
5 % I~-mercaptoethanol,  0.1 M sodium citrate, pH 5.5. Aliquots (50 ltl) were 
mixed with an equal volume of H20 and incubated with endoglycosidase 
H (endo H, 80 rig, Boehringer Mannheim Biochemicals, Indianapolis, IN) 
for 18 h at 37°C.  Endo H reactions were stopped by the addition of 0.5 vol 
of 3x SDS gel sample buffer.  Samples were heated for 5 min at 95°C and 
electrophoresed on 10% polyacrylarnide gels. 
Pulse-Chase Labeling of Uninfected Cells 
Cells growing in 100-mm dishes were pulse-labeled for 15 min with 0.5 mCi 
[35S]methionine/dish  in  methionine-free labeling medium.  The  labeling 
medium was removed and the cells were washed two times with DME and 
fed 3 ml of DME. At appropriate intervals after labeling, the medium was 
removed and centrifuged to remove cell debris. The supernatant was sup- 
plemented with I0 ~tg of sodium deoxycholate and secreted proteins were 
precipitated by the addition of  4 vol of  cold acetone. Cell-associated proteins 
were isolated as described for VSV-infected  cells. Secreted and cell-associ- 
ated proteins were solubilized in sample buffer, heated to 95°C, and size- 
separated on 6-12% polyacrylamide gels. 
Radioiodination Assay of  CeU Surface G Protein 
Ceils were grown in 35-mm culture dishes and infected with VSV at an MOI 
of 10 pfu/cell. At 4-5 hpi, the cells were labeled with 12~I by lactoperoxi- 
dase-catalyzed iodination at 4°C and lysed as described previously (Snider 
and Rogers, 1985). Lysates were incubated with anti-G protein monoclonal 
antibody for 2 h, goat anti-mouse IgG for 20 min, and protein A-Sephamse 
CL-4B for 2  h. All incubations were carded out at 4°C. The Sepharose 
beads were then washed extensively, as described previously (Strider  and 
Rogers, 1985).  lmmunoprecipitates were dissolved in SDS sample buffer, 
heated to 95°C for 5 min and analyzed by electrophoresis  on 10% polyacryl- 
amide gels. 
Binding and Internalization of Transferrin 
The preparation of J251-human transferrin was carried out as described pre- 
viously (Snider and Rogers,  1986).  Parental and mutant ceils growing in 
35-mm dishes were washed three times with cold Hepes-boffered MEM 
containing 1 mg/rnl BSA, and incubated for 30 rain on ice with 3  Ixg/ml 
~25I-transferrin. Cells were washed three times with cold Hepes-buffered 
MEM containing 1 mg/ml BSA and incubated at 37°C with Hepes-buffered 
MEM containing 60 I~g/ml unlabeled transferrin and 1% fetal bovine serum. 
At various times post temperature-shift, cultures were chilled and washed 
with Hepes-buffered MEM containing 1 mg/ml BSA. Cell-associated radio- 
activity was determined by dissolving the cells in 0.5% sodium dcoxycho- 
late and 0.5 N NaOH and counting in a gamma counter. Internal radioactiv- 
ity was measured by treating the cells briefly with acid prior to washing, 
which removes surface ligand (Klausner et al., 1983). Cell-surface radioac- 
tivity was calculated as the difference between the internal and total cell- 
associated  radioactivity.  Acid-insoluble  radioactivity  released  into  the 
medium was also measured. Values were corrected for nonspecific binding, 
which was measured in the presence of a 100-fold excess of unlabeled trans- 
ferrin. 
Results 
In an attempt to identify host cell functions that are essential 
for HSV infection we employed a genetic strategy designed 
originally to study interactions between bacteriophage lamb- 
da and Escherichia coli (reviewed by Friedman et al., 1984). 
Host mouse L cells were mutagenized with ethyl methane- 
sulfonate (EMS)  and then exposed to HSV  (see Materials 
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HSV is highly cytotoxic, there is strong selection for host cell 
mutants that fail to propagate HSV.  Using this method we 
selected 85 HSV-resistant clones from a starting population 
of roughly 10  s L cells. Following the nomenclature adopted 
by Friedman, Herskowitz, and Georgopoulos, we term these 
gro mutants in accordance with their inability to support vi- 
ral growth. 
One mutant, designated gro29, failed to produce any infec- 
tious virus when challenged with HSV. This failure could re- 
suit from a block to initial penetration of the virus. Alterna- 
tively, HSV might enter gro29 cells normally, but be blocked 
at some step during the expression or assembly of viral gene 
products. In order to distinguish between these alternatives, 
we compared the expression of viral antigens in gro29 and 
parental L  cells at successive intervals postinfection by in- 
direct immunofluorescence using anti-HSV antiserum (Fig. 
1). At 4 hpi, HSV antigens are observed in both cell types. 
The  nuclei  of infected  cells  exhibit the  brightest  fluores- 
cence, consistent with the expression of immediate-early and 
Figure 1.  Immunofluorescence analysis of HSV infec- 
tion  of  mouse  L  cells  and  gro29  cells.  Confluent 
monolayers of each  cell type were  inoculated with  a 
diluted stock of HSV-1 such that roughly  1 cell in 104 
became infected. The progress of  the viral infection was 
assayed by indirect immunofluorescence using a poly- 
clonal  antiserum  directed  against  HSV  polypeptides 
(see  Materials  and  Methods).  Fluorescence  micro- 
graphs of  parental cells (left) and mutant cells (right) are 
shown. The values to the right indicate the hpi when the 
cells in each row were fixed for analysis. The bottom 
row shows phase-contrast micrographs of the same cell 
monolayers depicted in the 20-hpi timepoint. 
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HSV-infected mouse L cells and gro29 cells. Monolayers of each 
cell type were infected at an MOI of 5 pfu/ceU with HSV-1 and la- 
beled  with  [35S]methionine. Cells  were  solubilized and labeled 
protein analyzed by SDS-PAGE. The patterns of polypeptide syn- 
thesis in mock-infecWA  cells labeled for 3 h (mock), and infected 
cells labeled 0-3 hpi (0-3) are the same for parental L cells and 
gro29 cells. The patterns differ, however, when the labeling period 
was carried out between 3 and 12 hpi (3-12). (Arrows) Polypeptides 
that accumulate to anomalously high levels in gro29 cells. Their ap- 
parent molecular masses are 51,000, 65,000, 90,000 and 110,000  dal- 
tons. Published estimates of the apparent molecular masses of the 
unprocessed HSV-1 glycoproteins are: gD = 51,000, gE = 66,000, 
gC  =  86,000-105,000, gA/B  =  110,000 daltons  (reviewed by 
Campadelli-Fiume and Serafini-Cessi, 1985). 
delayed-early viral  proteins  which  are  known  to  localize 
within the nucleus. At 8 hpi, fluorescence is again observed 
in both parental and mutant cells. By this time, however, the 
fluorescence  is  dispersed  throughout  both  nucleus  and 
cytoplasm.  In that viral antigens appear to accumulate in 
gro29 cells with the same kinetics as in parental L cells, and 
in that the same number of cells become infected when inoc- 
ulated with a constant amount of virus (data not shown), we 
conclude that HSV enters gro29 cells and begins its infec- 
tious cycle normally. 
Release of infectious virus by parental L cells is first de- 
tected at 12 hpi. This is clearly demonstrated in Fig. 1 where 
it can be seen that viral infection has spread to neighboring 
cells.  Parental L  ceils continue to release virus, and by 20 
hpi as many as 80 cells are included within each infectious 
center. In contrast, gro29 cells show no spread of the initial 
infection. Thus, despite the fact that gro29 cells synthesize 
viral antigens (Fig. 1) and viral DNA (data not shown) in an 
unimpeded manner, they appear incapable of releasing infec- 
tious virus. 
To follow the course of HSV infection of gro29 cells more 
closely, we radiolabeled proteins at several intervals postin- 
fection and fractionated them on SDS polyacrylamide gels 
(Fig. 2). Uninfected gro29 cells synthesized an array of  poly- 
peptides that  was  indistinguishable  from parental L  cells. 
When each cell type was infected with HSV and radiolabeled 
0-3 hpi, the patterns of  protein synthesis were again indistin- 
guishable.  That is,  HSV  succeeded in  extinguishing  host 
protein synthesis and inducing its own program of early gene 
expression in both cell types. In contrast, when the radio- 
labeling period was carried out between 3 and 12 hpi, HSV- 
infected gro29 cells did show differences from parental L 
cells. Four abundant polypeptide species were observed in 
gro29 cells that were not detected in L cells (Fig. 2, arrows). 
These observations suggest that a class of late viral proteins 
is aberrantly induced or processed in gro29 cells. 
The four polypeptides that accumulate aberrantly in gro29 
cells exhibit electrophoretic mobilities similar to immature 
HSV glycoproteins (Johnson and Spear,  1982; Campadelli- 
Flume and Serafini-Cessi,  1985).  Because it is known that 
pharmacologic blocks to glycoprotein transport or process- 
ing can inhibit HSV propagation (Johnson and Spear,  1982; 
Serafini-Cessi et al.,  1983),  we reasoned that gro29 ceils 
might be defective in the processing or transport of mem- 
brane glycoproteins. To evaluate this hypothesis, we exam- 
ined the ability of gro29 cells to synthesize, process, and 
transport the envelope glycoprotein (G protein) of VSV. We 
chose VSV because the processing and transport of  G protein 
has been thoroughly studied. As a first step, we performed 
virus plaque assays to compare VSV growth in L cells and 
gro29 cells. VSV  formed the same number of plaques on 
each cell type, indicating that binding and uptake of  virus oc- 
curs normally in gro29 cells (data not shown). The plaques 
formed on gro29 cells, however, were substantially smaller 
than those formed on L  cells.  These observations indicate 
that the block to VSV propagation in gro29 cells occurs after 
entry, and are consistent with the possibility that gro29 might 
impede the processing or transport of VSV G protein. 
We next monitored oligosaccharide processing and trans- 
port of G protein directly. In normal cells, G protein is syn- 
thesized on membrane-bound polyribosomes in the rough 
ER, and then transported through the Golgi complex to the 
cell  surface.  Two  asparagine-linked  oligosaccharides  are 
added to the polypeptide as high-mannose precursors which 
are converted to complex-type structures in the Golgi com- 
plex. Because endo H cleaves high-mannose chains, but not 
complex oligosaccharides, it serves as a useful probe for the 
processing of VSV G protein. 
Parental and gro29 cells were infected with VSV, pulse- 
labeled  with  [35S]methionine  for  10  min,  and  chased  for 
various times up to 3 h.  Cells were lysed and a fraction of 
each lysate was  digested with  endo H.  Digested and  un- 
digested aliquots were then analyzed by SDS-PAGE. We ob- 
served that all of the polypeptides encoded by VSV (L, G, 
N, NS, and M) were synthesized in comparable amounts in 
pulse-labeled L cells and gro29 cells (Fig. 3). Moreover, the 
G protein that was synthesized in the two cell lines was of 
similar size and was sensitive to digestion by endo H. Appar- 
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at an MOI of 10 pfu/cell with VSV in the presence of 2 Ixg/ml actinomycin D. Cells were pulse-labeled for 10 min with [3SS]methionine 
and chased for the indicated times. Aliquots of cell lysates were digested with endo H (see Materials and Methods). Digested (+) and 
mock-digested (-) lysates were subjected to SDS-PAGE. The five VSV proteins are identified by letters at the left of the figure. 
ently, insertion into the rough ER, cleavage of the signal pep- 
tide, and addition of high-mannose oligosaccharides to VSV 
G protein all occur normally in gro29 cells. The conclusion 
that early steps in the synthesis and posttranslational pro- 
cessing of G protein occur normally in gro29 cells is further 
supported by analyses of the oligosaccharides added to G 
protein in cells pulse-labeled with [3H]mannose. In pulse- 
labeled parental and gro29 cells,  GlcMangGlcNAc2 is  the 
predominant G protein oligosaccharide (M.  Snider, unpub- 
lished). This is the oligosaccharide normally found attached 
to G protein shortly after its synthesis (Li et al.,  1978). 
Although the initial synthesis of VSV G protein appears to 
occur normally in gro29 ceils, subsequent processing of the 
high-mannose oligosaccharides is clearly aberrant (Fig. 3). 
In parental L cells, G protein becomes endo H-resistant very 
rapidly; processing is complete between 20 and 40 min after 
labeling. These observations are in agreement with previous 
reports that have demonstrated the rapid processing of VSV 
G protein (Strous and Lodish, 1980; Lodish and Kong, 1983; 
Rose and Bergmann, 1983; Machamer et al.,  1985). In con- 
trast to the rapid processing of G protein in L cells, gro29 
cells are slow to convert the endo H-sensitive, high-mannose 
oligosaccharides of G protein to the endo H-resistant state. 
By 40 min after labeling,  only 50%  of the G  protein has 
Figure 4. Comparison of the rate of appearance 
of newly synthesized VSV G protein in virions 
released from mouse L cells and gro29 cells. 
Virions were isolated from the chase medium 
in a pulse-chase experiment identical to the one 
shown in Fig. 3. Aliquots of each sample were 
digested with endo H. Digested (+) and mock- 
digested (-) samples were subjected to SDS- 
PAGE. The time after pulse-labeling when the 
virions were collected is indicated above each 
pair of lanes. The five  VSV proteins are iden- 
tiffed at the left of the figure. 
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protein in VSV-infected mouse 
L cells and gro29 cells.  Cells 
were  grown  on  glass  cover- 
slips and infected at an MOI of 
5 pfu/cell  with VSV. In order 
to detect total G protein,  cells 
were fixed at 4 hpi, permeabi- 
lized, and probed with a mono- 
clonal  antibody  specific  to 
VSV G protein (see Materials 
and  Methods).  Fluorescence 
micrographs of (A) parental  L 
cells  and (B) gro29 cells  are 
shown in the left column (cor- 
responding phase-contrast mi- 
crographs of the  same  fields 
are  shown  in  the  right  col- 
umn).  To visualize  surface  G 
protein,  living cells were incu- 
bated  at 4 hpi with anti-VSV 
G,  followed  by  fluorescein- 
conjugated  goat  anti-mouse 
Fab. Fluorescence and phase- 
contrast  micrographs  of (C) 
parental  L cells and (D) gro29 
cells  are shown.  Bar, 40 lam. 
achieved the endo H-resistant  state.  The data presented  in 
Fig. 3 also show that gro29 cells accumulate novel forms of 
VSV G protein. One form appears to be smaller than mature 
G protein and another appears larger (diagnosed by relative 
electrophoretic mobilities).  In gro29 cells  54%  of radiola- 
beled G protein accumulates as the largest species (see Fig. 
3).  These novel  forms presumably  represent  species  of G 
protein that have abnormal oligosaccharides. The structures 
of these aberrant oligosaccharides are currently being exam- 
ined.  Coupled with the delayed acquisition of sensitivity to 
endo H, these data provide strong evidence that gro29 cells 
are defective in the processing of VSV G  protein. 
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they are defective in enzymatic functions directly required 
for the conversion of high-mannose oligosaccharides to their 
more mature forms  Alternatively, the defect may impair the 
transport of glycoproteins from the ER through the Golgi 
complex to the cell surface. To determine whether transport 
is impeded in gro29 cells, we tracked the appearance of la- 
beled VSV proteins in virions during the chase period of an 
experiment identical to  that described in  Fig.  3.  Culture 
medium was collected 1, 2, or 3 h after the pulse. Virions 
were then isolated from the medium by centrifugation, solu- 
bilized, digested with endo H, and electrophoresed on an 
SDS-polyacrylamide gel  (Fig.  4).  When virions  derived 
from gro29 cells were compared with those derived from pa- 
rental L cells, similar amounts of all virion proteins were ob- 
served with one exception. After 1 h of chase, the amount 
of labeled G protein in virions, normalized to the amount of 
labeled N+NS proteins is only 4%  the level of parental L 
cells. By 3 h after labeling, this value reached only 30%. We 
have not determined whether virions released from gro29 
cells contain the  same amount of G  protein (labeled and 
unlabeled)  as  those  released  from L  cells.  However,  the 
impeded flux of labeled G protein into virions released from 
gro29 ceils supports the possibility that this mutant may be 
defective in the intracellular transport of glycoproteins. 
Based on these results, we reasoned that VSV G protein 
might accumulate within infected gro29 cells. Likewise, the 
amount of G protein that reached the cell surface of gro29 
cells might be expected to be reduced relative to parental L 
cells. Two experiments were performed to test these hypoth- 
eses. First, the location ofVSV G protein in parental and mu- 
tant cells was studied by immunofluorescence microscopy 
using an anti-VSV G protein monoclonal antibody. In paren- 
tal L cells that have been infected with VSV, fluorescence is 
observed on both surface and intracellular structures (Fig. 5 
A). In contrast, VSV-infected gro29 cells exhibit intense jux- 
tanuclear  fluorescence and  minimal  surface  fluorescence 
(Fig. 5 B). To visualize the cell surface-associated G protein 
exclusively, living cells were incubated with the anti-VSV G 
monoclonal antibody followed by a fluorescein-conjugated 
Fab fragment. As expected, VSV-infected parental L cells ex- 
hibit strong surface fluorescence (Fig. 5 C) when compared 
with the amount detected on the surface of gro29 cells (Fig. 
5 D). 
The second approach that was used to study G  protein 
transport involved immunoprecipitation of surface-labeled 
proteins.  After lactoperoxidase-catalyzed iodination, cell- 
surface proteins were solubilized and subjected to immuno- 
precipitation with a monoclonal antibody to VSV G protein. 
Precipitated protein was sized by SDS-PAGE, which allowed 
quantitation of the amount of G protein on the surface of pa- 
rental and mutant cells. These data (not shown) indicate that 
at 5 hpi, gro29 cells contain only 25 % as much G protein 
on their surface as parental L ceils. 
We attempted to define the intracellular compartment of 
gro29 cells where VSV G protein accumulates by comparing 
the G protein distribution to that of binding sites for WGA. 
WGA binds to terminal sialic and GlcNAc residues of glyco- 
proteins which are added in the Golgi complex (reviewed by 
Schachter and Roseman, 1980); thus WGA-binding sites are 
found in the Golgi apparatus, as well as in organelles con- 
taining molecules that have passed through the Golgi corn- 
plex (Virtanen et al., 1980). To evaluate the location of VSV 
G protein and WGA in the same cells, we carried out double- 
labeling  experiments using fluorescein-labeled WGA and 
rhodamine-labeled goat anti-mouse IgG. The upper panel of 
Fig. 6 shows the location of VSV G protein in gro29 cells, 
and the lower panel shows the distribution of WGA-binding 
sites in the same cells. The two markers exhibit substantial 
colocalization, particularly in a juxtanuclear structure that 
probably corresponds to the Golgi complex. 
It is unlikely that the defect in gro29 is restricted to the 
transport of viral glycoproteins. Uninfected gro29 cells ex- 
hibit a doubling time twice that of parental L cells. They also 
fail to grow in reduced serum medium that is known to sup- 
port the growth of parental L cells (Tufaro, E, unpublished 
observation). In the light of these observations, we extended 
our characterization of gro29 cells to determine whether the 
secretion of endogenous proteins was impeded relative to pa- 
rental L  cells. L  cells and gro29 cells were pulse-labeled 
with [35S]methionine. Cell-associated and secreted proteins 
were isolated at several intervals after labeling and analyzed 
by SDS-PAGE (Fig. 7). We observed no marked difference 
in the qualitative pattern of polypeptides synthesized by the 
two cell types, nor did we notice any quantitative difference 
in label incorporation. In contrast, we did observe distinct 
differences in the patterns of polypeptides secreted during 
the chase period. Of four prominent polypeptides secreted 
by both cell types (indicated by arrows), three were secreted 
from gro29 cells with delayed kinetics. Furthermore, a num- 
ber of polypeptides appeared to migrate on SDS polyacryl- 
amide gels as discrete species when secreted from parental 
L  cells, but as diffuse species when secreted from gro29 
cells. 
Observations presented thus far suggest that gro29 cells 
may be defective in the transport of newly synthesized pro- 
teins to the cell surface. If this is the case, it is of interest 
to know whether endocytic  processes are also affected in this 
mutant. This was tested by comparing the receptor-mediated 
endocytosis of transferrin in parental and gro29 cells. Trans- 
ferrin, the serum iron carrier, binds to a specific receptor on 
the cell surface and is rapidly internalized. The iron then dis- 
sociates, most likely in the acidic endosomal compartment, 
and the receptor-transferrin complex returns to the cell sur- 
face where apoprotein-transferrin is released (reviewed by 
May and Cuatrecasas,  1985). 
To  examine the  endocytosis and release of transferrin, 
parental  and gro29  cells were exposed to  t25I-transferrin, 
washed and incubated in unlabeled culture medium at 37°C. 
At various times after binding, the amounts of surface and 
internal t2~I-transferrin were determined. In addition,  t25I- 
transferdn release into the culture medium was measured at 
each time point.  Parental and gro29  cells contain similar 
numbers  of cell  surface  transferdn receptors.  As  Fig.  8 
shows,  more importantly, they internalize and release 125I- 
transferdn (J25I-Tf) into the medium at similar rates. In both 
cell types most of the surface 125I-transferdn is internalized 
within 10 min, and 80% is returned to the surface and re- 
leased into the medium within 30 min. These results suggest 
that endocytic processes occur normally in gro29 cells. 
Discussion 
This report describes the preliminary characterization of a 
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a juxtanuclear  compartment of gro29 cells. 
gro29 cells were grown on glass coverslips 
and infected at an MOI of 10 pfu/cell with 
VSV. Cells were fixed at 4 hpi, and Golgi 
and post-Golgi  regions were visualized with 
fluorescein-conjugated  wheat germ aggluti- 
nin (see Materials  and Methods).  VSV G 
protein was visualized in the same cells by 
indirect immunofluorescence  using an anti- 
G monoclonal IgG followed by rhodamine- 
conjugated  goat anti-mouse IgG. Fluores- 
cence micrographs revealing G protein (top) 
and WGA (bottom) in the same field of cells 
were obtained using barrier filters that pre- 
vent crossover between rhodamine and flu- 
orescein fluorescence.  Bar,  15 Ixm. 
The Journal of Cell Biology, Volume 105, 1987  654 Figure 7. Comparison of newly synthesized polypeptides secreted from mouse L cells and gro29 cells. Monolayers of each cell type were 
pulse-labeled for 15 min with [35S]methionine  and chased for the indicated times. Cell-associated proteins were prepared by lysing cell 
monolayers after extensive washing with PBS (see Materials and Methods). Aliquots of cell-associated and secreted proteins were subjected 
to SDS-PAGE. (Asterisk) A prominent cell-associated protein that leaked into the secreted fraction. (A, B, C, and D) Prominent secreted 
polypeptides. Polypeptides B, C, and D are underrepresented in the culture supernatant from gro29 cells at the 60-min timepoint after 
labeling. Molecular mass markers (kD) are shown at the left of the figure. 
mammalian cell mutant that is defective in the intracellular 
transport  of glycoproteins.  Although  we  have  not  as  yet 
mapped or identified the mutation that causes gro29 cells to 
display the transport-defective phenotype, we believe that it 
is a bona fide somatic cell mutant. First, HSV-resistant mu- 
tants were retrieved from our initial screen at a  frequency 
similar to that reported for the generation of other somatic 
cell  mutants  (about  1  in  106). Second,  the  phenotype of 
gro29 is stable; it reverts to the HSV-sensitive phenotype at 
a rate lower than 1 in 106 (Tufaro, E, and S. McKnight, un- 
published data). Finally, the phenotype of gro29 appears to 
be unrelated to its initial exposure to HSV; it does not contain 
episomal or integrated copies of the HSV genome (Tufaro, 
E, and S. McKnight, unpublished observation), and it does 
not express viral antigens in the absence of infection (see 
Fig.  1). 
How could a mutant blocked late in infection have survived 
our selection procedure? One possibility is that the surviving 
mutants escaped initial HSV infection during the selection. 
In that mutagenized cells were allowed to grow for 7 d before 
infection, small colonies of mutant cells were formed. When 
the cultures were subsequently inoculated with virus,  cell 
colonies, particularly mutants incapable of virus propaga- 
tion, might have provided a  "microenviroument" that pro- 
tected central cells from infection. Alternatively, gro29 cells 
might be capable of surviving the cytopathic effects induced 
by HSV infection prior to the egress of virions from the cell. 
We are currently testing this possibility. Regardless of the 
reason for the survival of gro29, it is clear that this selection 
procedure is useful for isolating mutants that interfere with 
the HSV lytic infectious cycle. 
We have shown by a number of different criteria that VSV 
G protein transport is defective in gro29 cells. These include 
biochemical demonstration of  the retardation of  oligosaccha- 
ride maturation on newly made VSV  G  protein,  and  im- 
munologic demonstration of the accumulation of G protein 
in a juxtanuclear compartment of infected cells. Perhaps the 
most convincing demonstrations of the transport defect in 
gro29 cells come from measurements of G protein flux to the 
surface of infected cells, and from direct measurements of 
the rate of appearance of G protein in virions. In both cases 
we were able to document a marked lag in the intracellular 
transport of G protein. 
What  type of physiologic defect could account  for the 
phenotype of gro29? For several reasons we doubt that its 
phenotype results from an alteration in an enzymatic step in- 
volved in oligosaccharide synthesis or processing. First, in- 
hibitors of oligosaccharide processing, including deoxyman- 
nojirimycin and deoxynojirimycin,  potent inhibitors of Golgi 
mannosidase I and ER glucosidases, respectively, drastically 
alter oligosaccharide processing but do not affect intracellu- 
lar G protein transport (Burke et al., 1984; Schlesinger et al., 
1984).  Second, several different defects in the processing of 
VSV G protein oligosaccharides are seen in gro29 cells, in- 
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Figure 8.  Endocytosis and  release of transferrin  are  similar  in 
mouse L cells and gro29 cells. Cells were incubated with t~I-trans- 
ferrin for 30 min at 0°C to saturate surface binding sites. They were 
then washed and incubated at 37°C in medium containing unlabeled 
transferrin for the indicated times. The amount of  radioactive trans- 
ferrin that was cell associated (e), surface associated (o), internal 
(m) or free in the medium (A) was determined for L cells (top 
panel) and gro29 cells (bottom  panel) as described in Materials and 
Methods. 
cluding slow acquisition of endo H resistance, as well as the 
accumulation of novel mature forms. If these defects are due 
to a single lesion in the glycosylation  pathway, then the lesion 
must occur very early in oligosaccharide synthesis.  How- 
ever, we have found that the early stages of asparagine-linked 
glycosylation are normal in gro29 cells; the synthesis of the 
precursor oligosaccharide, its transfer to protein,  and the 
removal of glucose residues by ER glucosidases are identi- 
cal in mutant and parental cells (Snider,  M.,  unpublished 
observation). 
An alternative explanation for the defect of gro29 cells is 
that it affects several stages of membrane glycoprotein trans- 
port including passage from the ER to the Golgi complex, 
and subsequent movement to the cell surface. A reduction in 
the rate of interorganelle transfer would account for the slow 
rate of oligosaccharide processing as well as for the slow 
transit of VSV G protein from ER to the cell surface. If such 
is the case, some element common to all of these transfer 
reactions might be defective, possibly related to the forma- 
tion, movement or fusion of transport vesicles. 
It may be worth noting that the defects of gro29 cells are 
similar to some of the effects of the monovalent cation iono- 
phore monensin (Johnson and Schlesinger, 1980). Monensin 
disrupts  the  morphology of the  Golgi apparatus,  causing 
a  distinct  swelling  of the  cisternae  (Quinn  et  al.,  1983). 
Monensin is also known to retard transport of newly made 
membrane glycoproteins and  secretory proteins (Tartakoff 
and  Vassalli,  1977, 1978; Johnson  and  Schlesinger,  1980; 
Strous and Lodish,  1980; Tartakoff, 1983).  In the presence 
of monensin, glycoproteins are transported into the medial 
Golgi compartment where they are converted to endo H-re- 
sistant forms, but do not progress to the trans compartment. 
It is possible that the smaller endo H-resistant form of G pro- 
tein observed in gro29 cells represents material that has been 
exposed to GlcNAc transferases in the medial Golgi (Dunphy 
et al.,  1985), but has not been acted on by the terminal Gal 
and sialytransferases in the trans compartment of the Golgi 
complex. In addition, ifG protein is kept in a Golgi compart- 
ment for an abnormally long time, oligosaccharide process- 
ing activities specific to that compartment might process G 
protein aberrantly. For example, the larger G protein species 
may represent oligosaccharides that are "oversialylated" due 
to an extended lifespan in the trans compartment of  the Golgi 
complex. Direct tests of  these hypotheses can now be carried 
out by determining the structures of  the oligosaccharides that 
are found on VSV G protein in gro29 cells. 
It is unlikely that gro29 is defective in all aspects of vesicu- 
lar transport. We found that the receptor-mediated uptake 
and release of transferrin occurs normally in the mutant cell 
line.  Moreover,  VSV,  which  enters  cells  by  endocytosis 
(Marsh, 1984), penetrates gro29 cells in an unimpeded man- 
ner. Finally, gro29 and parental L cells are equally sensitive 
to the cytotoxic lectin modeccin (Tufaro, F., unpublished ob- 
servation).  Because modeccin enters cells by endocytosis 
(Sandvig and Olsnes, 1982), this result also suggests that en- 
docytosis is normal in gro29 cells. 
We are aware of two reports in the literature that concern 
variant  mammalian  cells  affected in  intracellular  protein 
trafficking.  Robbins et al.  (1984)  have isolated a  Chinese 
hamster ovary (CHO) cell mutant, termed DTG 1-5-4,  that 
is defective in receptor-mediated endocytosis and partially 
impaired  in  glycoprotein maturation.  Although  the  latter 
phenotypic property of DTG 1-5-4 is similar to that ascribed 
to  gro29  in  this  report,  it  is  improbable  that  they  have 
suffered lesions in the same genetic locus.  Unlike gro29, 
Dq~ 1-5-4 cells are highly resistant to modeccin and defec- 
tive in endocytosis. Nakano et al. (1985) have described an- 
other CHO mutant,  termed DS28-6,  that is conditionally 
defective in protein export. DS28-6 is reported to be incapa- 
ble of releasing VSV virions at its nonpermissive tempera- 
ture.  Informative comparisons  among gro29,  DTG  1-5-4, 
and DS28-6 are problematic in that the mutants have been 
characterized either by different functional tests or to differ- 
ent levels of detail. 
Perhaps the most surprising observation to come from this 
study is the complete inability of infected gro29 cells to shed 
infectious HSV. In contrast, gro29 cells produce •35%  of 
the normal amount of infectious VSV particles. It is perhaps 
the case that the relevant difference in the production of these 
two viruses by gro29 cells is due to the different sites of 
virion assembly. VSV assembly begins in the cytoplasm and 
is completed when nucleocapsids bud from the plasma mem- 
brane. In contrast, HSV virions begin assembly in the nu- 
cleus, become enveloped as they exit the nucleus, and are 
then believed to be transported from the ER to the Golgi 
complex en route to the plasma  membrane (Johnson and 
Spear,  1982).  We speculate that the egress of HSV virions 
taxes the intracellular transport apparatus to its limits. Thus, 
defects that are sublethal to the transport of cellular glyco- 
The Journal of Cell Biology, Volume  105,  1987  656 proteins (as well as VSV G protein), might completely elimi- 
nate the production of infectious HSV. 
Regardless of the explanation for the effect of the lesion in 
gro29 cells on the release of infectious HSV virions, we have 
shown that the defect is extremely strong. We are encouraged 
that the selection scheme outlined in this report will facilitate 
the isolation of additional mutants that are defective in glyco- 
protein transport.  Indeed, preliminary studies indicate that 
more than half of the HSV-resistant  lines that we have iso- 
lated block virus propagation at a late stage of the infectious 
cycle (Tufaro,  F.,  and S.  McKnight,  unpublished observa- 
tion). We hope that this study  represents the starting point 
for a genetic attack on glycoprotein transport in mammalian 
cells. 
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